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Background and aims: Data on cutaneous malignant melanoma (CMM), squamous
cell carcinoma of the skin (SCC), and basal cell carcinoma (BCC) in populations
consisting of multi‐racial groups in the Commonwealth of Independent States are lim-
ited. Here, the main aim was to analyse the incidence and body site of these cancers
in the population groups of Astana, Kazakhstan (2007‐2016).
Methods: Annual age standardised incidences and body sites of BCC, SCC, and
CMM in Astana's population, divided into “Kazakhs and other Turkic/Asian” and “Rus-
sian and other European/Caucasian” groups, were calculated from histologically con-
firmed cases reported to Astana Oncology Centre.
Results: During the period January 2007 to October 2016, 647 skin cancers were
diagnosed. The age and sex standardised incidence of BCC, SCC, and CMM increased
significantly between 2007 to 2011 and 2012 to 2016. Higher incidences occurred in
the Russian and other European/Caucasian group compared with the Kazakh and
other Turkic/Asian group for the 3 skin cancers. BCC was the most common type
of skin tumour, followed by SCC, and then CMM, in both population groups and
sexes. The head/neck was the commonest site for BCC and SCC in all groups. For
CMM, the most frequent site was the trunk in the Russian group and the head/neck
in the Kazakh group.
Conclusion: The incidence of skin tumours in Astana rose over the past 10 years.
Differences in skin phototypes and sun exposure/ protection behaviours may account
for the more frequent occurrence of skin tumours in the Russian population group
compared with the Kazakh population group.
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carcinoma of the skin1 | INTRODUCTION
Information on the incidence of the most common skin cancers,
cutaneous malignant melanoma (CMM), squamous cell- - - - - - - - - - - - - - - - - - - - - - - - - - -
e Creative Commons Attribution Li
lished by Wiley Periodicals, Inc.carcinoma of the skin (SCC), and basal cell carcinoma (BCC),
is available for many Western countries1-3 but is limited for
Commonwealth of Independent States (former Soviet Republics)
such as Kazakhstan. This is particularly true for locations- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
cense, which permits use, distribution and reproduction in any medium, provided
wileyonlinelibrary.com/journal/hsr2 1 of 6
2 of 6 MCLOONE ET AL.&C?JRFѥ1AGCLACѥ0CNMPRQwhere the population is multi‐ethnic, containing a range of skin
phototypes.
Kazakhstan is a former Soviet Republic that became independent
following the dissolution of the Soviet Union in 1991. Its capital city
was transferred to Astana in 1997. At the time of the 2009 census,
Astana's population comprised 89.1% Kazakhs, 4.5% Russians, 0.9%
Ukrainians, and 2.4% Uzbeks.4 Since 2009, Astana's population
increased by around 50%, and was 872 619 in 2016,5 consisting of
75.5% Kazakhs, 15.3% Russians, 1.6% Ukrainians, 1.1% Uzbeks, 1%
Germans, and several minority groups.6 Astana has an extreme conti-
nental climate, with warm summers and long, cold winters. It can be as
hot as +35°C in the summer, while in the winter temperatures as low
as −35°C are not uncommon. The UV index ranges from 1 in the win-
ter to 7 in July/August, and daily hours of sunshine vary from 3 in
November/December to 11 in June/July.7 Astana is located in a flat
steppe region, encompassing 722 km2, and lies at latitude 51.60N, lon-
gitude 71.5°E, and altitude 347 m.
Data from the Ministry of Health in Kazakhstan (2015) indicate
that skin cancer is one of the most common forms of cancer in the
country,8 but a detailed analysis relating to the population groups in
Kazakhstan has not previously been reported. In this study, the inci-
dence and body sites of BCC, SCC, and CMM in the multi‐national
populations of Astana were investigated.2 | METHODS
Information on histologically confirmed cases of CMM, BCC, and SCC,
diagnosed in Astana between the years 2007 and 2016, was obtained
from the Astana Oncology Centre. The Astana Oncology Centre is a
cancer diagnostic and treatment centre where all histologically con-
firmed skin cancer cases are accurately registered in a central oncol-
ogy register. The centre serves the population of Astana and treats
inpatients as well as outpatients. The Institutional Research Ethics
Committee of Nazarbayev University granted institutional review
board exemption for the study, based on the fact that the study did
not involve the participation of human subjects, and that only de‐iden-
tified histologically confirmed skin cancer cases from the Astana
Oncology Centre cancer registry would be used for the analysis. Fur-
thermore, patients diagnosed with skin cancer at the Astana Oncology
Centre were informed that their data could be used for research. The
type of skin cancer, age at diagnosis, sex, nationality, cancer stage,
body site, and date of diagnosis were recorded. Nationality, a parame-
ter commonly recorded in hospitals and clinics in Kazakhstan, was
determined from passports or identity cards. Counts of the population
of Astana by age, sex, and nationality were obtained from the 2009
population census.4 Mid‐year population estimates for 2017 by age
and sex, along with estimated proportions of national groups, were
obtained from the Ministry of National Economy of the Republic of
Kazakhstan, Committee on Statistics (2017).
Across and within the different population groups of Astana,
there is a considerable range of nationalities and skin phototypes.
For the purposes of this study, we classified Russians, Ukrainians,
Germans, Belarusians, Chechens, and Poles as European/Caucasian
skin types, and Kazakhs, Tatars, Uzbeks, Koreans, Azerbaijanis, Turks,Bashkirs, Uyghurs, Dungans, and Tajiks as Turkic/Asian skin types.
The numbers of skin cancers in the Kazakh and Russian populations
were assessed separately and then combined with other Turkic/Asian
and other European/Caucasian, respectively, for calculation of inci-
dence and percentage of specific cancer body site location, because
the numbers in the minority groups were small. The percentage of
SCC, BCC, and CMM reported to occur on the head/neck, trunk,
upper extremity, and lower extremity was calculated for the years
2007 to 2016 in the 2 groups: Kazakh and other Turkic/Asian, and
Russian, and other European/Caucasian.
For all skin cancers and each type, direct age standardised (ages
20+) incidence rates expressed per 100 000 population with 95% con-
fidence intervals were produced for all of Astana's population for the
grouped years 2007 to 2011 and 2012 to 2016. For the period
2007 to 2011, the population denominators were taken from the
2009 population Census. For the period 2012 to 2016, the denomina-
tor for rates were taken from interpolated 2014 mid‐year population
estimates. We did not use different nationality counts for this period.
The reference population for the age standardisation was the Euro-
pean standard population.9 For the period 2007 to 2011, age
standardised rates were calculated for the population grouped into
Russian and other European/Caucasian, and Kazakh and other
Turkic/Asian. Age standardised rates for the period 2012 to 2016
for the population grouped into Russian and other European/Cauca-
sian and Kazakh and other Turkic/Asian were not produced because
counts of the population divided by age, sex, and ethnic group were
not available for the inter‐census years 2012 to 2016.
Differences in categorical demographic and clinical characteristics
of patients by cancer type were assessed using Pearson chi‐square
test or Monte Carlo permutation tests of independence, when appro-
priate. Kruskal‐Wallis test was used to test for differences in median
age. All tests were 2‐sided, and the standard significance level of
0.05 was used throughout. Statistical analyses were performed using
Stata v14.0.3 | RESULTS
Between January 2007 and October 2016, 647 skin cancers were
diagnosed. The age of the patients at diagnosis ranged from 10 to
91 years (median 66, IQR 56‐73). Table 1 shows that 58.9% of cancers
were found in women and 41.1% in men, with the majority in the Rus-
sian population (46.7%), followed by the Kazakh population (26.6%).
The most common cancer type was BCC (67.9%), followed by SCC
(15.3%), and then CMM (11.9%). The most frequent body site was
the head/neck (73%), followed by the trunk (12.1%), the lower
extremity (7.1%), and the upper extremity (4.3%). The majority of the
skin cancers were stage I (76%).3.1 | Characteristics by cancer type
Table 2 indicates whether there was an association between patient
demographic/clinical characteristics and type of cancer. The median
age of patients with BCC, SCC, and CMM was 66, 68, and 57 years,
respectively. Median age (95% CI) of CMM patients was lower than
TABLE 1 Preliminary analysis of skin cancer cases recorded at
Astana Oncology Centre 2007 to 2016
Characteristics N (%)
Sex Men 266 (41.1)
Women 381 (58.9)
Nationality Russian 302 (46.7)
Kazakh 172 (26.6)
Other European/Caucasian 133 (20.6)
Other Turkic/Asian 38 (5.9)
Not reported 2 (0.3)
Cancer type SCC 99 (15.3)
BCC 439 (67.9)
CMM 77 (11.9)
Other 32 (5.0)
Stage I 492 (76.0)
II 130 (20.1)
III 14 (2.2)
IV 4 (0.6)
Not reported 7 (1.1)
Site Head and neck 472 (73.0)
Trunk 78 (12.1)
Lower extremity 46 (7.1)
Upper extremity 28 (4.3)
Not reported 23 (3.6)
MCLOONE ET AL. 3 of 6&C?JRFѥ1AGCLACѥ0CNMPRQmedian age of patients with BCC or SCC (57 (54 to 62) years, 66 (65
to 68) years, 68 (64 to 71) years, respectively; Kruskal‐Wallis test
P = 0.01). More than 50% of CMM cases were reported as stage II
or higher, compared with 25% and 15% of SCCs and BCCs, respec-
tively. Head/neck was the most common site for SCCs and BCCs,
but CMM was more uniformly distributed across body sites. A higher
proportion of skin cancers were located on the trunk in men compared
with women (17.7%, 95%CI [13.2 to 22.8%] vs 8.1% [5.6 to 11.4%],
Pearson chi‐square P < 0.001), and on the lower extremity in women
compared with men (9.4%, 95% CI [6.7 to 12.8%] vs 3.8% [1.8 to
6.8%], Pearson chi‐square P = 0.006).TABLE 2 Characteristics of skin cancer cases
SCC BCC
Characteristics N (%) N
Sex Men 34 (34.3) 184
Women 65 (65.7) 255
Median age (IQR) 68 (56–77) 66
Nationality Russian 49 (49.5) 209
Kazakh 28 (28.3) 100
Other European/Caucasian 16 (16.2) 102
Other Turkic/Asian 6 (6.1) 26
Not reported 0 (0.0) 2
Stage I 74 (74.7) 369
II 23 (23.2) 62
III 2 (2.0) 3
IV 0 (0.0) 2
Not reported 0 (0.0) 3
Site Head and neck 78 (78.8) 362
Trunk 6 (6.1) 40
Upper extremity 6 (6.1) 12
Lower extremity 8 (8.1) 12
Not reported 1 (1.0) 13
The P value for sex by cancer type is from Pearson chi‐square test of heterogen
and women. The P value for age comes from Kruskal‐Wallis test which tests wh
nationality, stage, and site are from tests of heterogeneity. Each tests whether
identical across stage, and identical across site. A permutation test based on th3.2 | Body site of CMM, BCC, and SCC in the
population groups
The commonest body site for BCCs and SCCs was the head/neck in all
population groups and in both males and females. For CMM, the most
frequent body site was the head/neck in Kazakh and other Turkic/
Asians (34.4%) and the trunk in Russian and other European/Cauca-
sians (35.6%). However, for each cancer, there was no statistically sig-
nificant association between body site and national group (Table 3).3.3 | Age standardised incidence of CMM, BCC, and
SCC
During the study period, the age and sex standardised incidence rate
of skin cancer increased from 22.1 per 100 000 in 2007 to 2011 to
53.1 per 100 000 in 2012 to 2016. This large rise in incidence was
seen in all cancer types and in both sexes (Table 4). Men generally
had a higher incidence of skin cancer than women, with the exception
of SCC in both time periods, and CMM in 2012 to 2016.3.4 | Age standardised incidence of CMM, BCC, and
SCC in the Russian and other European/Caucasian and
Kazakh and other Turkic/Asian groups
The incidence of skin cancer among the Russian and other European/
Caucasian group during 2007 to 2011 was 81.0 per 100 000 for men
and 57.3 for women. This was 1321% and 559% greater than that
experienced by the Kazakh and other Turkic/Asian group, respec-
tively, in whom the equivalent rates were 5.7 and 8.7 per 100 000
(Table 5). Rates were higher in the Russian and other European/Cau-
casian group for each cancer type, and the relative differential
between European/Caucasian and Turkic/Asian was greater among
men compared with women.CMM Other
(%) N (%) N (%) P‐Value
(41.9) 32 (41.6) 16 (50.0) P = 0.38
(58.1) 45 (58.4) 16 (50.0)
(58–73) 57 (46–65) 63 (50.5–73.5) P < 0.001
(47.6) 34 (44.2) 10 (31.3) P = 0.09
(22.8) 28 (36.4) 16 (50.0)
(23.2) 11 (14.3) 4 (12.5)
(5.9) 4 (5.2) 2 (6.3)
(0.5) 0 (0.0) 0 (0.0)
(84.1) 37 (48.1) 12 (37.5) P < 0.001
(14.1) 32 (41.6) 13 (40.6)
(0.7) 6 (7.8) 3 (9.4)
(0.5) 1 (1.3) 1 (3.1)
(0.7) 1 (1.3) 3 (9.4)
(82.5) 18 (23.4) 14 (43.8) P < 0.001
(9.1) 24 (31.2) 8 (25.0)
(2.7) 8 (10.4) 2 (6.3)
(2.7) 20 (26.0) 6 (18.8)
(3.0) 7 (9.1) 2 (6.3)
eity. This tests whether frequency counts are distributed identically in men
ether distribution of age is the same for each cancer type. The P values for
cancer type frequency counts are distributed identically across nationality,
e chi‐square statistic was used.
TABLE 3 The number and percentage (in brackets) of squamous cell carcinoma of the skin (SCC), basal cell carcinoma (BCC), and cutaneous
malignant melanoma (CMM) reported to occur on 4 body sites in Kazakh and other Turkic/Asian and European/Caucasian population groups
(2007‐2016)
Cancer National Grouping Head and Neck Trunk Upper Extremity Lower Extremity Not Reported P‐Value
SCC Kazakh and other Turkic/Asian 26 (76.5) 4 (11.8) 1 (2.9) 2 (5.9) 1 (2.9) 0.19
Russian and other European/Caucasian 52 (80.0) 2 (3.1) 5 (7.7) 6 (9.2) 0 (0.0)
BCC Kazakh and other Turkic/Asian 109 (86.5) 6 (4.8) 3 (2.4) 6 (4.8) 2 (1.6) 0.10
Russian and other European/Caucasian 252 (81.0) 33 (10.6) 9 (2.9) 6 (1.9) 11 (3.5)
CMM Kazakh and other Turkic/Asian 11 (34.4) 8 (25.0) 1 (3.1) 10 (31.3) 2 (6.3) 0.12
Russian and other European/Caucasian 7 (15.6) 16 (35.6) 7 (15.6) 10 (22.2) 5 (11.1)
Other Kazakh and other Turkic/Asian 7 (38.9) 5 (27.8) 2 (11.1) 3 (16.7) 1 (5.6) 0.82
Russian and other European/Caucasian 7 (50.0) 3 (21.4) 0 (0.0) 3 (21.4) 1 (7.1)
P‐values are for Fishers exact test for heterogeneity. This tests whether frequency counts are distributed identically across different populations.
TABLE 4 Age standardised incidence of CMM, BCC, and SCC in
Astana, Kazakhstan (2007‐2016)
Age Standardised Incidence Rate per 100 000
(95% CI)
Cancer 2007‐2011 2012‐2016
Men Skin cancers 23.6 (18.4 to 28.9) 54.9 (47.0 to 62.8)
SCC 1.9 (0.6 to 3.2) 7.7 (4.8 to 10.7)
BCC 18.5 (13.7 to 23.4) 37.6 (30.6 to 43.4)
CMM 2.2 (0.9 to 3.4) 4.6 (2.6 to 6.6)
Women Skin cancers 20.6 (16.5 to 24.6) 51.2 (45.2 to 57.1)
SCC 4.6 (2.7 to 6.5) 8.4 (5.9 to 10.9)
BCC 14.9 (11.4 to 18.5) 33.4 (28.6 to 38.2)
CMM 0.9 (0.2 to1.5) 5.1 (3.5 to 6.7)
TABLE 5 Age standardised incidence of CMM, BCC, and SCC in the
Russian and European/Caucasian, and the Kazakh and Turkic/Asian
population groups in Astana, Kazakhstan (2007‐2011)
Age Standardised Incidence Rate per 100 000
(95% CI) (2007‐2011)
Cancer
Russian and other
European/Caucasian
Kazakh and other
Turkic/Asian
Men Skin cancers 81.0 (60.0 to 102.0) 5.7 (3.3 to 8.2)
SCC 6.9 (0.9 to 13.0) 0.4 (0.0 to 0.8)
BCC 64.2 (45.4 to 82.9) 4.0 (1.6 to 6.3)
CMM 6.9 (0.9 to 12.9) 1.4 (0.4 to 2.4)
Women Skin cancers 57.3 (43.6 to 71.1) 8.7 (5.7 to11.7)
SCC 14.1 (6.7 to 21.5) 3.1 (1.0 to 5.3)
BCC 38.4 (27.6 to 49.1) 4.8 (2.7 to 7.0)
CMM 3.6 (0.0 to 7.6) 0.6 (0.0 to 1.1)
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This study has shown that there was a higher incidence of skin cancer
in the Russian and other Caucasian/European group than in the
Kazakh and other Turkic/Asian group in Astana. In addition, a substan-
tial increase in the incidence rate of skin cancer in both men and
women occurred between 2007 to 2011 and 2012 to 2016.
The photo‐protection offered by epidermal melanin is a possible
factor explaining the differences in incidence between national
groups.10 Although epidermal melanin content and phototype were
not measured in the present study, Kazakh and Turkic/Asian people,
in general, have more pigmented skin than Russian and European/
Caucasian people. The incidence of BCC, SCC, and CMM in Astana
is lower than that reported in European countries. For example, inScotland, incidence rates in 2009 for CMM, BCC, and SCC in males
were 17.3, 122.5, and 50.5, respectively, and in females were 20.3,
90.3, and 18.8, respectively.1 The incidence of non‐melanoma and
melanoma skin cancers in Asian populations, such as in Singapore
and Japan, is also lower than in predominantly Caucasian populations
in Europe, USA, and Australia.11-14 Apart from phototype, other fac-
tors which may differ between the population groups include personal
photo‐protective measures, typical clothing, and outdoor/indoor occu-
pations. These were not investigated in the present study.
As was found in Astana, BCC is the most common skin cancer in
other Caucasian and Asian populations.15,16 In Astana, the incidence
of BCC was higher in Caucasian/European men than women. An
increased incidence of BCC in males has previously been reported in
European countries and may be due to higher sun exposure in men,
who tend to have more outdoor work, expose a larger area of their
skin, and are less likely to use sun protection than women.1,17 Con-
versely, the incidence of BCC was higher in Kazakh and other
Turkic/Asian females than in males, which may be due to differences
in occupational or recreational exposures or sun protection practices
or awareness. In agreement with other studies in Caucasian and Asian
population groups, the head/neck was the most common site for BCC
in both groups and sexes in Astana.18,19
Similar to results in studies involving Caucasian, Chinese Asian,
and Japanese populations, the second most common type of skin can-
cer in Astana was SCC.1,15,16,19 The incidence of SCC in females was
consistently higher than in males in Astana, which is the converse of
that reported in several European countries.1,20 The reasons for the
higher incidence of SCC in women in Astana are not clear, but a study
conducted in the Japanese population of Hawaii also demonstrated a
higher incidence of BCC and SCC in females than males.19 The authors
proposed that cultural and occupational differences between men and
women may be responsible.
CMM was the least frequent skin cancer in Astana; the age
adjusted incidences were slightly higher in men than women for both
population groups. This is similar to reports of slightly higher inci-
dences of CMM in men than women for Caucasian and Asian popula-
tion groups.15,21 Conversely, in Japan, it has been reported that
malignant melanoma occurs more frequently in females than males.15
The most common body site for CMM in the Kazakh and other Turkic
Asian group was the head and neck, whereas it was the trunk in the
Caucasian/European group. However, when the population groups
MCLOONE ET AL. 5 of 6&C?JRFѥ1AGCLACѥ0CNMPRQwere divided with both sexes combined, no statistically significant
association between national group and cancer site was found. The
most frequent body site for CMM was the trunk for Russian males
and the head and neck for Kazakh males, whilst it was the lower
extremity for both Russian and Kazakh females. It has previously been
reported that the predominant body site for CMM in Caucasian
women and Caucasian men is the lower extremity and trunk, respec-
tively.22 Interestingly, the sole of the foot was the commonest body
sites for CMM in Japan, with acral lentiginous melanoma being the
most frequent subtype.23 The difference in body site for CMM
between Kazakh and Russian males in Astana may have been due to
differences in the melanoma subtype; such information was not
recorded in the cancer registry.
A limitation of our study is that it is based on a specialist oncol-
ogy centre registry and not on a population‐based cancer registry.
Therefore, the incidence of non‐melanoma skin cancer is likely to
underestimate the true incidence, as tumours may be treated topically
without histological verification, treated privately, or not treated at all.
Differential use of health services over time and among different pop-
ulation groups may contribute to the rise in incidence rates and dif-
ferences between groups. We could not assess how much of the
rise in skin cancer incidence was due to changes in national composi-
tion, because population counts by age, sex, and national group were
not available for the inter‐census years 2012 to 2016. We were also
limited to using projected population estimates for 2014 which makes
the analysis less reliable for this time‐period. A strength of the study
is that it is one of the first to report skin cancer rates in a multi‐
national transitional population during a period in which the popula-
tion has rapidly expanded, partly due to an influx of Russian and other
European groups.
The World Health Organisation has attributed the rising world-
wide incidence of skin cancer to depletion of the ozone layer, and
increasing outdoor activities and recreational exposures.24,25 Thinning
of the ozone layer has varied over the world, with most of it at polar
latitudes: it has been insignificant over Kazakhstan, thus making ozone
depletion as a local risk factor for skin cancer development unlikely.26
It is more likely that exposure to solar ultraviolet radiation (UVR) lead-
ing to sunburn and unprotected chronic exposures as a result of soci-
etal changes in behaviour have contributed to the increased risk of
skin cancer found in the present study. Public health messages regard-
ing protection of the skin from the damaging effects of UVR have yet
to be adequately promoted in Kazakhstan [personal communication,
Dr Khalel Imanbayev]. The implementation of educational sun protec-
tion programmes in schools and public forums in Kazakhstan is
required to raise awareness of the carcinogenic effects of UVR expo-
sure and hopefully to halt the steep rise in the incidence of skin cancer
that has occurred over the past 10 years.FUNDING
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